Alembic Pharmaceuticals surges on incorporating subsidiary in Thailand
Alembic Pharmaceuticals is currently trading at Rs. 715.70, up by 9.30 points or 1.32% from its previous closing of Rs. 706.40 on the BSE.
The scrip opened at Rs. 706.10 and has touched a high and low of Rs. 719.95 and Rs. 706.10 respectively. So far 1417 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1107.80 on 30-Jun-2025 and a 52 week low of Rs. 671.00 on 02-Mar-2026.
Last one week high and low of the scrip stood at Rs. 723.50 and Rs. 687.20 respectively. The current market cap of the company is Rs. 14079.82 crore.
The promoters holding in the company stood at 69.74%, while Institutions and Non-Institutions held 20.41% and 9.86% respectively.
Alembic Pharmaceuticals incorporated a subsidiary named Alembic Pharmaceuticals (Thailand) Co., in Thailand. The company has incorporated the subsidiary to explore new business opportunities in this geography to promote, sale and distribute pharmaceuticals product(s) of the company.
The Company holds 99.99% stake in Alembic Pharmaceuticals (Thailand) Co.
600-400.jpg)
